Two-Pronged attack: new drug trial targets tough lung cancers

NCT ID NCT04995523

Ongoing Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This study is testing a new experimental drug called AZD2936 for people with advanced non-small cell lung cancer (NSCLC) that has spread. The drug is designed to work like two drugs in one, targeting two different pathways that cancer cells use to hide from the immune system. Researchers want to find the safest and most effective dose and see if it can help shrink tumors or control the cancer's growth.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Research Site

Chicago, Illinois, 60637, United States
Research Site

Rochester, Minnesota, 55905, United States
Research Site

Fairfax, Virginia, 22031, United States
Research Site

Melbourne, 3000, Australia
Research Site

Anderlecht, 1070, Belgium
Research Site

Leuven, 3000, Belgium
Research Site

Florianópolis, 88034-000, Brazil
Research Site

Natal, 59075-740, Brazil
Research Site

Porto Alegre, 90035903, Brazil
Research Site

Rio de Janeiro, 20231-050, Brazil
Research Site

São Paulo, 01246-000, Brazil
Research Site

Chengdu, 610041, China
Research Site

Chongqing, 400030, China
Research Site

Copenhagen, 2100, Denmark
Research Site

Dijon, 21079, France
Research Site

Toulouse, 31059, France
Research Site

Tbilisi, 0112, Georgia
Research Site

Kashiwa, 227-8577, Japan
Research Site

Niigata, 951-8566, Japan
Research Site

Sendai, 981-0914, Japan
Research Site

Tokyo, 104-0045, Japan
Research Site

Kuala Lumpur, 59100, Malaysia
Research Site

Kuching, 93586, Malaysia
Research Site

Chisinau, MD-2025, Moldova
Research Site

Groningen, 9713 GZ, Netherlands
Research Site

Leiden, 2333 ZA, Netherlands
Research Site

Utrecht, 3584 CX, Netherlands
Research Site

Seoul, 03082, South Korea
Research Site

Seoul, 03722, South Korea
Research Site

Seoul, 05505, South Korea
Research Site

Barcelona, 08035, Spain
Research Site

Madrid, 28027, Spain
Research Site

Madrid, 28041, Spain
Research Site

Taichung, 40201, Taiwan
Research Site

Taichung, Taiwan
Research Site

Tainan, 70403, Taiwan
Research Site

Taipei, 110, Taiwan
Research Site

Bangkok, 10700, Thailand
Research Site

Chanthaburi, 22000, Thailand
Research Site

Muang, 50200, Thailand

Conditions

Explore the condition pages connected to this study.

NON SMALL CELL LUNG CARCINOMA